Sandeep “Steve” Laumas, MD

Dr. Laumas has over two decades of experience in healthcare investments in both private and public companies and has served on the board of directors of publicly traded biotechnology companies, including BioXcel Therapeutics (Nasdaq: BTAI) and 9 Meters Biopharma (Nasdaq: NMTR).

Since 2014, Dr. Laumas has served on the board of directors of private and publicly traded biotechnology companies. In 2008, Dr. Laumas founded Bearing Circle Capital, an investment vehicle, and has served as its Managing Director since such time. Dr. Laumas began his career at Goldman Sachs & Co. in 1996 as an equity analyst in the healthcare investment banking division, working on mergers & acquisitions and corporate finance transactions before transitioning to the healthcare equity research division. After leaving Goldman Sachs in 2000, Dr. Laumas moved to the buy side as an analyst at Balyasny Asset Management from 2001 to 2003. Dr. Laumas was a Managing Director of North Sound Capital from 2003 to 2007 and was responsible for the global healthcare investment portfolio. Dr. Laumas has served as a member of the board of directors of private and public healthcare companies, including Parkway Holdings Ltd. (2010), SRL Ltd. (2011-2012), 9 Meters Biopharma, Inc. (Nasdaq: NMTR) (2018-present) and BioXcel Therapeutics, Inc. (Nasdaq: BTAI) (2017-present). Dr. Laumas received his A.B. in Chemistry from Cornell University in 1990, his MD from Albany Medical College in 1995 with a research year at the Dana-Farber Cancer Institute, and completed his medical internship in 1996 from the Yale University School of Medicine.